Inspire Veterinary Partners, Inc. Class A (IVP) AI Stock Analysis

• Market Cap: $6.17M
• Dividend Yield: N/A
• Average Volume (3M): 1.94M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.84
• Revenue Growth: -10.70%
• EPS Growth: 99.69%
• Country: US
• Employees: 113
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Personal Products & Services
• EPS (TTM): -0.50
• Shares Outstanding: 3,609,285
• 10 Day Avg. Volume: 66,872
• 30 Day Avg. Volume: 1,943,145
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 4.46
• Enterprise Value/Revenue: 1.80
• Enterprise Value/Gross Profit: 7.39
• Enterprise Value/Ebitda: -3.00
• 1Y Price Target: $1.00
• Price Target Upside: -9.91% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 41 Neutral
• Price Target: $1.00 ▼(-9.91% Downside)

Inspire Veterinary Partners, Inc. is facing significant financial difficulties, with declining revenues and high leverage being the most impactful factors. Technical analysis shows a bearish trend, and valuation metrics indicate potential overvaluation. The lack of earnings call data and corporate events leaves these areas unaddressed.

Inspire Veterinary Partners, Inc. Class A Business Overview & Revenue Model

Company Description

Inspire Veterinary Partners, Inc. Class A (IVP) is a company operating within the veterinary services sector. It focuses on providing comprehensive veterinary care solutions, including medical services, surgical procedures, and preventive health care for pets. The company aims to enhance the quality of life for animals through advanced veterinary practices and compassionate care.

How the Company Makes Money

Inspire Veterinary Partners, Inc. makes money primarily through the provision of veterinary services at its network of clinics. Revenue is generated from fees charged for medical consultations, diagnostic tests, surgical procedures, and preventive care services such as vaccinations and wellness exams. Additionally, the company may earn income through the sale of pet-related products, including prescription medications, pet food, and wellness products. Significant partnerships with pet insurance providers and pet product manufacturers could also contribute to its earnings by facilitating access to a broader customer base or offering exclusive services and products.

Inspire Veterinary Partners, Inc. Class A Financial Statement Overview

Summary

Inspire Veterinary Partners, Inc. faces significant financial challenges with declining revenues, high leverage, and negative profitability margins. Despite some improvement in free cash flow, the overall financial health remains weak, with potential risks due to high debt levels and negative equity.

Income Statement

Inspire Veterinary Partners, Inc. shows a concerning trend in its income statement. The company has experienced a significant revenue decline of 69.4% in the TTM period, with negative net profit margins consistently above -80%. The gross profit margin has also decreased from 41.3% in 2024 to 24.3% in the TTM. These figures indicate challenges in maintaining profitability and revenue growth.

Balance Sheet

The balance sheet reveals high leverage with a debt-to-equity ratio of 31.88 in the TTM, indicating significant reliance on debt financing. The return on equity is negative, reflecting the company's inability to generate profits from shareholders' equity. The equity ratio is low, suggesting potential financial instability.

Cash Flow

Cash flow analysis shows improvement in free cash flow growth at 12.08% in the TTM, but operating cash flow remains negative. The free cash flow to net income ratio is slightly above 1, indicating that free cash flow is covering net losses. However, the negative operating cash flow to net income ratio highlights ongoing operational challenges.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	15.29M	16.59M	16.68M	9.83M	2.55M	0.00
Gross Profit	3.72M	6.86M	3.55M	2.55M	829.29K	0.00
EBITDA	-9.16M	-9.50M	-10.84M	-2.91M	-977.46K	0.00
Net Income	-12.91M	-14.26M	-14.79M	-4.91M	-1.33M	-5.52K
Balance Sheet
Total Assets	20.81M	20.20M	21.79M	20.19M	6.33M	21.97K
Cash, Cash Equivalents and Short-Term Investments	158.94K	523.69K	178.96K	444.25K	2.06M	21.97K
Total Debt	14.23M	16.37M	18.42M	23.61M	6.69M	0.00
Total Liabilities	20.36M	18.63M	22.58M	25.32M	7.20M	0.00
Stockholders Equity	446.26K	1.56M	-788.26K	-5.14M	-869.09K	21.97K
Cash Flow
Free Cash Flow	-9.32M	-10.24M	-4.20M	-2.84M	-2.32M	-5.52K
Operating Cash Flow	-9.26M	-10.01M	-3.82M	-2.66M	-1.01M	-5.52K
Investing Cash Flow	-1.94M	-238.00K	-1.87M	-14.67M	-4.02M	0.00
Financing Cash Flow	11.39M	10.59M	5.63M	15.71M	7.07M	269.16K

Inspire Veterinary Partners, Inc. Class A Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 1.11
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IVP, the sentiment is Neutral. The current price of 1.11 is above the 20-day moving average (MA) of 0.92, above the 50-day MA of 0.86, and below the 200-day MA of 1.99, indicating a neutral trend. The MACD of 0.02 indicates Negative momentum. The RSI at 69.06 is Neutral, neither overbought nor oversold. The STOCH value of 87.42 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IVP.

Inspire Veterinary Partners, Inc. Class A Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MRM	54 Neutral	12.33M	8.87	15.94%	―	12.93%	66.81%
IVP	41 Neutral	$6.17M	―	-809.91%	―	-10.70%	99.69%
EJH	40 Neutral	21.70M	―	―	―	-11.14%	98.81%
XWEL	40 Neutral	6.04M	-0.27	2138.71%	―	-6.93%	22.70%
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%

Inspire Veterinary Partners, Inc. Class A Corporate Events

Inspire Veterinary Partners Regains Nasdaq Compliance

Inspire Veterinary Partners, Inc. announced on September 2, 2025, that it has regained compliance with Nasdaq’s Stockholders’ Equity Requirement after previously being notified on April 10, 2025, about non-compliance. The company received confirmation of compliance from Nasdaq on August 26, 2025, based on its Form 8-K filed with the SEC on August 20, 2025.

Inspire Veterinary Partners Raises $5M for Nasdaq Compliance

Inspire Veterinary Partners, Inc. faced a compliance issue with Nasdaq’s minimum stockholders’ equity requirement, as disclosed on April 10, 2025. The company submitted a compliance plan on May 23, 2025, and subsequently entered into a Securities Purchase Agreement on July 28, 2025, to issue Series B convertible preferred stock and warrants, raising approximately $5 million in the first closing on July 29, 2025. This move is believed to have brought the company back into compliance with Nasdaq’s requirements, although Nasdaq will continue to monitor the situation to ensure ongoing compliance.

Inspire Veterinary Partners Secures $5M in Series B Funding

On July 28, 2025, Inspire Veterinary Partners, Inc. entered into a Securities Purchase Agreement with accredited investors to issue up to 7,590 shares of Series B convertible preferred stock and accompanying warrants, potentially raising up to $10 million. The first closing on July 29, 2025, resulted in $5 million in proceeds. The company plans to use the funds for working capital, acquisitions of veterinary practices, and to address Nasdaq deficiencies. This move aligns with Inspire’s growth strategy and aims to enhance its market positioning by expanding its healthcare services.

Inspire Veterinary Partners Acquires Debary Animal Clinic

On June 5, 2025, Inspire Veterinary Partners, Inc. completed the acquisition of Debary Animal Clinic and its related real estate assets in Florida, marking its fifth acquisition in the state. This acquisition is expected to add approximately $1.8 million in annual revenue and increase the company’s network of animal hospitals to 14, enhancing its presence in the Florida pet care market.

Inspire Veterinary Partners Issues Discount Notes for Capital

On May 30, 2025, Inspire Veterinary Partners, Inc. issued Original Issue Discount Notes to 1800 Diagonal Lending LLC and Boot Capital LLC, with principal amounts of $204,700 and $92,000 respectively, to be used for general working capital. These notes, which mature on March 30, 2026, include provisions for interest payments and allow the lenders to convert the debt into shares of the company’s common stock under certain conditions, impacting the company’s financial strategy and stakeholder interests.